1. Home
  2. FSBW vs HELP Comparison

FSBW vs HELP Comparison

Compare FSBW & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FS Bancorp Inc.

FSBW

FS Bancorp Inc.

HOLD

Current Price

$40.80

Market Cap

295.4M

Sector

Finance

ML Signal

HOLD

HELP

Cybin Inc. Common Stock

N/A

Current Price

$5.56

Market Cap

249.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FSBW
HELP
Founded
1936
N/A
Country
United States
Canada
Employees
537
50
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
295.4M
249.0M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
FSBW
HELP
Price
$40.80
$5.56
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$46.00
$51.50
AVG Volume (30 Days)
8.1K
638.5K
Earning Date
04-24-2026
07-01-2026
Dividend Yield
2.84%
N/A
EPS Growth
N/A
N/A
EPS
4.29
N/A
Revenue
$4,612,000.00
N/A
Revenue This Year
$14.94
N/A
Revenue Next Year
$10.47
N/A
P/E Ratio
$9.52
N/A
Revenue Growth
44.80
N/A
52 Week Low
$36.72
$4.29
52 Week High
$44.22
$8.55

Technical Indicators

Market Signals
Indicator
FSBW
HELP
Relative Strength Index (RSI) 55.20 55.08
Support Level $39.44 $4.40
Resistance Level $40.67 $8.55
Average True Range (ATR) 1.16 0.30
MACD 0.30 0.16
Stochastic Oscillator 76.21 94.85

Price Performance

Historical Comparison
FSBW
HELP

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of First Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being investigated for potential use in the treatment of depression, anxiety, and other mental health conditions, areas where there is an unmet medical need. It aims to provide treatments designed for mental health disorders. The company is currently developing HLP003, a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of substantial depressive disorder. It operates in Canada, the United States, the United Kingdom, and Ireland.

Share on Social Networks: